Health Insurance (Variation of Fees and Medical Services) (No. 5) Regulations (Cth)

Statutory Rules

1977 No. 126

 

REGULATIONS UNDER THE HEALTH INSURANCE ACT 1973.*

I, THE GOVERNOR-GENERAL of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the Health Insurance Act 1973.

Dated this twenty-eighth day of July, 1977.

JOHN R. KERR.

Governor-General.

By His Excellency’s Command,

RALPH J. HUNT

Minister of State for Health

________

 

HEALTH INSURANCE (VARIATION OF FEES AND MEDICAL SERVICES) (No. 5) REGULATIONS

Citation.

1. These Regulations may be cited as the Health Insurance (Variation of Fees and Medical Services) (No. 5) Regulations.

Commencement.

2.These Regulations shall come into operation on 1 August 1977.

Health Insurance (Variation of Fees and Medical Services) (No. 4) Regulations—amendment of Schedule.

3. The Schedule to the Health Insurance (Variation of Fees and Medical Services) (No. 4) Regulations is amended as set out in the Schedule to these Regulations.

          

______________________________________________________________________________

* Notified in the Commonwealth of Australia Gazette on 29 July 1977.

SCHEDULE

AMENDMENTS OF THE SCHEDULE TO THE HEALTH INSURANCE

(VARIATION OF FEES AND MEDICAL SERVICES) (No. 4) REGULATIONS

Amendments of the Rules for the Interpretation of the Table of Medical Services

1.  After rule 5, insert the following rules:—

“ 5a. Where an item in Part 7 includes the symbol ‘ (SP) ’, the item shall be taken to relate to a pathology service to which paragraph 16a (1) (a) applies when rendered by or on behalf of an approved pathology practitioner who—

(a) is a recognized pathologist; or

(b) employs a recognized pathologist by whom, or under whose supervision, the service is rendered,

other than a pathology service—

(c) rendered in pursuance of a request made in the course of the provision of an out-patient service at a recognized hospital;

(d) rendered in pursuance of a request made in respect of a person who was, at the time that the request was made, a private patient in a recognized hospital; or

(e) in the rendering of which—

(i) any pathology equipment of a recognized hospital is used; or

(ii) any member of the staff of a recognized hospital participates.

“ 5b. In rule 5a, ‘ recognized pathologist ’ means a medical practitioner who, by reason of a determination under section 61, is to be recognized for the purposes of the Act as a specialist in the specialty of pathology.

“ 5c. Where an item in Part 7 includes the symbol ‘ (OP) ’, the item shall be taken to relate to a pathology service to which paragraph 16a (3) (a) or (b) applies other than a service included in an item that includes the symbol ‘(SP)’.

“ 5d. Each item in Division 9 of Part 7 shall be taken to relate to a pathology service to which paragraph 16a (1) (c) applies. “,

2.  After rule 10, insert the following rules:—

“ 10a. Where—

(a) a procedure of one of 2 or more kinds of procedure described in an item in Part 7 (being an item that is expressed to apply in relation to one procedure) that includes the symbol ‘ (SP) ’; or

(b) a procedure of one of 2 or more kinds of procedure described in an item in Part 7 (being an item that is expressed to apply in relation to one procedure) that includes the symbol ‘ (OP) ’,

is rendered in respect of a person by or on behalf of an approved pathology practitioner in pursuance of a request, made on a day, addressed to that approved pathology practitioner (in this rule referred to as ‘the first-mentioned approved pathology practitioner’)—

(c) by the practitioner who determined that the procedure was necessary; or

(d) by another approved pathology practitioner who is not the practitioner who determined that the procedure was necessary,

being the only such request in respect of a procedure of that kind, or any other kind described in that item, made on that day in respect of that person to the first-mentioned approved pathology practitioner by that practitioner or that other approved pathology practitioner, that procedure shall be treated as one service consisting of that procedure.

“ 10b. Where—

(a) 2 or more procedures each of which is a procedure of one of 2 or more kinds of procedure described in an item in Part 7 (being an item that is expressed, whether directly or indirectly, to apply to that number of procedures) that includes the symbol ‘ (SP) ’; or

(b) 2 or more procedures each of which is a procedure of one of 2 or more kinds of procedure described in an item in Part 7 (being an item that is expressed, whether directly or indirectly, to apply to that number of procedures) that includes the symbol ‘ (OP) ’,

are rendered in respect of a person by or on behalf of an approved pathology practitioner in pursuance of a request, or requests made on the one day, addressed to that approved pathology practitioner (in this rule referred to as ‘ the first-mentioned approved pathology practitioner ’)—

(c) by the practitioner who determined that the procedures were necessary; or

Schedule—continued

(d) by another approved pathology practitioner who is not the practitioner who determined that the procedures were necessary,

those procedures shall, unless the contrary intention appears, be treated as one service consisting of those procedures.

“ 10c. Where—

(a) a procedure of one of 2 or more kinds of procedure described in an item in Part 7 (being an item that is expressed to apply in relation to one procedure) that includes the symbol ‘ (OP) ’, being a procedure determined on a day to be necessary by an approved pathology practitioner (being a medical practitioner) or by an employee (being a medical practitioner) of an approved pathology practitioner in the course of that employment, is rendered in respect of a person by or on behalf of that approved pathology practitioner; and

(b) that procedure is the only procedure of that kind, or any other kind described in that item, that was so determined on that day to be necessary in respect of that person by that approved pathology practitioner, that employee or any other employee (being a medical practitioner) of that approved pathology practitioner,

that procedure shall be treated as one service consisting of that procedure.

“ 10d. Where 2 or more procedures each of which, is a procedure of one of 2 or more kinds of procedure described in an item in Part 7 (being an item that is expressed, whether directly or indirectly, to apply to that number of procedures) that includes the symbol ‘ (OP) ’, being procedures determined on the one day to be necessary by an approved pathology practitioner (being a medical practitioner) or by an employee (being a medical practitioner) of an approved pathology practitioner in the course of that employment, are rendered in respect of a person by or on behalf of that approved pathology practitioner, those procedures shall, unless the contrary intention appears, be treated as one service consisting of those procedures.

“ 10e. Where—

(a) a procedure of one of the kinds of procedure described in item 2334 is rendered in respect of a person (in this rule referred to as ‘the first-mentioned person’) by or on behalf of a medical practitioner other than an approved pathology practitioner (in this rule referred to as ‘the first-mentioned practitioner’) and—

(i) the procedure was determined to be necessary by the first-mentioned practitioner; or

(ii) the procedure, was rendered in pursuance of a request made by the person who determined that the procedure was necessary, being a medical practitioner (other than an approved pathology practitioner) who, at tire time the request was made, was a member of a group of practitioners of which the first-mentioned practitioner was then a member; and

(b) that procedure is the only procedure of that kind, or any other kind included in that item, that, on the day on which tire procedure was determined to fee necessary or on which, the request for the procedure was made, as the case may be, was—

(i) so determined to be necessary in respect of the first-mentioned person by the first-mentioned practitioner; or

(ii) so requested in respect of the first-mentioned person by a medical practitioner (other than an approved pathology practitioner) who, on that day, was a member of a group of practitioners of which the first-mentioned practitioner was then a member,

that procedure shall be treated as one service consisting of that procedure.

“ 10f. Where—

(a) 2 or more procedures each of which is a procedure of one of the kinds of procedure described in item 2335 or 2336 are rendered in respect of a person by or on behalf of a medical practitioner other than an approved pathology practitioner (in this rule referred to as ‘ the first-mentioned practitioner ’);

(b) each of the procedures was—

(i) determined to be necessary by the first-mentioned practitioner; or

(ii) rendered in pursuance of a request made by the person who determined that the procedure was necessary, being a medical practitioner (other than an approved pathology practitioner) who, at the time the request was made, was a member of a group of practitioners of which the first-mentioned practitioner was then a member; and

Schedule—continued

(c) each of the procedures was so determined to be necessary, or so requested, on the one day,

those procedures shall be treated as one service consisting of those procedures.

“10g. In rules 10a to 10f (inclusive), ‘procedure’ includes an assay, an estimation and a test.”.

Amendments of the Table of Medical Services
1. Omit items 827 and 829, substitute the following item:—
“ 831 Declotting of an arteriovenous shunt .........	37.00		37.00	37.00		37.00			37.00	37.00 ”.
2. Omit item 836, substitute the following item:—
“ 836 Peritoneal dialysis, establishment of by abdominal puncture and insertion of temporary catheter (including associated consultation) ........................	40.00	40.00		40.00		40.00		40.00		40.00 ”.
3. Omit item 859, substitute the following items:—
“ 859 Retinal photography, multiple exposures of one eye with intravenous dye injection....................................................	42.00	42.00		42.00	42.00		42.00			42.00
“ 860 Retinal photography, multiple exposures of both eyes with intravenous dye injection ...................................................	53.00	53.00		53.00	53.00		53.00			53.00 ”.
4. Omit item 888, substitute the following items:—
“ 887 Group psychotherapy (including associated consultations) of not less than 1 hours duration given under the continuous direct supervision of a consultant physician in She practice of his specialty of psychiatry, involving a group of 2–9 unrelated patients or a family group of more than 3 patients, each of whom is referred to the consultant physician by a medical practitioner—each patient ....................	15.00		15.00	15.00		15.00	15.00			15.00
“ 888 Group psychotherapy (including associated consultations) of not less than 1 hours duration given under the continuous direct supervision of a consultant physician in the practice of his specialty of psychiatry, involving a family group of 3 patients, each of whom is referred to the consultant physician by a medical practitioner—each patient .............................................	19.40		19.40	19.40		19.40	19.40			19.40
“ 889 Group psychotherapy (including associated consultations) of not less than 1 hours duration given under the continuous direct supervision of a consultant physician in the practice of his specialty of psychiatry, involving a family group of 2 patients, each of whom is referred to the consultant physician by a medical practitioner—each patient..............................................	29.00		29.00	29.00		29.90	29.00			29.00 ”.

Schedule—continued

5. After item 974, insert (in Division 8 of Part 6) the following items:—
“ 976 Counterpulsation by intra-aortic balloon—management on the first day, including initial and subsequent consultations and monitoring of parameters ..............	168.00	168.00	168.00	168.00	168.00	168.00
“ 977 Counterpulsation by intra-aortic balloon—management on each day subsequent to the first, including associated consultations and monitoring of parameters................................................	40.00	40.00	40.00	40.00	40.00	40.00 ”.
6. Omit Divisions 9 and 10 of Part 6, substitute the following Division:—
“ Division 9
“987 Skin sensitivity testing for allergens, using one to twenty allergens .........................	11.60	11.60	11.60	11.60	11.60	11.60
“ 989 Skin sensitivity testing for allergens, using more than twenty allergens....................	17.60	17.60	17.60	17.60	17.60	17.60 ”.
7. Omit Part 7, substitute the following Part:—

“ Part 7—Pathology Services

Division 1—Haematology

“ 1006 Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count—one procedure (SP) .................	3.10	3.10	2.90	2.60	2.60	2.60
“ 1007 Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count—one procedure (excluding Wood count consisting of haemoglobin estimation or erythrocyte sedimentation rate when not referred by another medical practitioner) (OP)	2.35	2.35	2.20	1.95	1.95	1.95
“ 1008 Two procedures to which item 1006 applies (SP) ............................................	5.00	5.00	4.60	4.20	4.20	4.20
“ 1009 Two procedures to which item 1007 applies (OP) ............................................	3.75	3.75	3.45	3.15	3.15	3.15
“ 1010 Three or more procedures to which item 1006 applies including calculation of erythrocyte indices where done (SP) .	7.50	7.50	6.90	6.30	6.30	6.30
“ 1011 Three or more procedures to which item 1007 applies including calculation of erythrocyte indices where done (OP)	5.65	5.65	5.20	4.75	4.75	4.75
“ 1014 Blood film, examination of—including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (SP) ...................................................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1015 Blood film, examination of—including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (OP) ...................................................................	4.65	4.65	4.30	3.90	3.90	3.90

Schedule—continued

“ 1019 Blood film, examination by special stains to demonstrate, the presence of basophilic stippling, eosinophils (where wet preparation or film is used), haemoglobin H, reticulocytes, or similar conditions, cells or substances—one procedure (SP)	2.50	2.50	2.30	2.10	2.10	2.10
“ 1020 Blood film, examination by special stains to demonstrate the presence of basophilic stippling, eosinophils (where wet preparation or film, is used), haemoglobin H reticulocytes, or similar conditions, cells or substances—one procedure (OP)	1.90	1.90	1.75	1.60	1.60	1.60
“ 1021 Two or more procedures to which item 1019 applies (SP)	3.70	3.70	3.40	3.10	3.10	3.10
“ 1022 Two or more procedures to which item 1020 applies (OP)	2.80	2.80	2.55	2.35	2.35	2.35
“ 1028 Blood film, examination by special stains to demonstrate the presence of foetal haemoglobin, Heinz bodies, iron, malarial or other parasites, neutrophil alkaline phosphatase, PAS, Sudan black positive granules, sickle cells, or any similar cells, substances or parasites—one procedure (SP)	3.70	3.70	3.40	3.10	3.10	3.10
“ 1029 Blood film, examination by special stains to demonstrate the presence of foetal haemoglobin, Heinz bodies, iron, malarial or other parasites, neutrophil alkaline phosphatase, PAS, Sudan black positive granules, sickle cells, or any similar cells, substances or parasites—one procedure (OP)	2.80	2.80	2.55	2.35	2.35	2.35
“ 1030 Two or more procedures to which item 1028 applies (SP)	6.20	6.20	5.70	5.20	5.20	5.20
“ 1032 Two or more procedures to which item 1029 applies (OP)	4.65	4.65	4.30	3.90	3.90	3.90
“ 1036 Erythrocytes, qualitative assessment of metabolism or haemolysis by—erythrocyte autohaemolysis test, erythrocyte fragility test (mechanical), glucose-6-phosphate dehydrogenase estimation, glutathione deficiencies test, pyruvate kinase estimation or sugar water test (or similar) for paroxysmal nocturnal haemoglobinuria—one procedure (SP)	6.20	6.20	5.70	5.20	5.20	5.20
“ 1037 Erythrocytes, qualitative assessment of metabolism or haemolysis by—erythrocyte autohaemolysis test, erythrocyte fragility test (mechanical), glucose-6-phosphate dehydrogenase estimation, glutathione deficiencies test, pyruvate kinase estimation or sugar water test (or similar) for paroxysmal nocturnal haemoglobinuria—one procedure (OP)	4.65	4.65	4.30	3.90	3.90	3.90

Schedule—continued

“ 1038 Two or more procedures to which item 1036 applies (SP) ..................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1040 Two or more procedures to which item 1037 applies (OP)	9.40	9.40	8.65	7.90	7.90	7.90
“ 1044 Erythrocytes, quantitative assessment of metabolism or haemolysis by—acid haemolysis test (or similar) for paroxysmal nocturnal haemoglobinuria, erythrocyte fragility to hypotonic saline test without incubation, erythrocyte fragility to hypotonic saline test after incubation, glutathione stability test, glucose-6-phosphate dehydrogenase estimation, or pyruvate kinase estimation—one procedure (SP) .......................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1045 Erythrocytes, quantitative assessment of metabolism or haemolysis by—acid haemolysis test (or similar) for paroxysmal nocturnal haemoglobinuria, erythrocyte fragility to hypotonic saline test without incubation, erythrocyte fragility to hypotonic saline test after incubation, glutathione stability test, glucose-6-phosphate dehydrogenase estimation, or pyruvate kinase estimation—one procedure (OP) ......................................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1048 Two or more procedures to which item 1044 applies (SP) ..................................	25.00	25.00	23.00	21.00	21.00	21.00
“ 1049 Two or more procedures to which item 1045 applies (OP) ..................................	18.75	38.75	17.25	15.75	15.75	15.75
“ Bone Marrow Examination
“ 1062 Bone marrow examination (including use of special stains where indicated) of bone marrow aspirate, dot section or trephine section—one procedure (SP) ...................................................................	37.50	37.50	34.50	31.50	31.50	31.50
“ 1063 Bone marrow examination (including use of special stains where indicated) of bone marrow aspirate, clot section or trephine section—one procedure (OP)	28.15	28.15	25.90	23.65	23.65	23.65
“ 1064 Two or more procedures to which item 1062 applies (SP) ..................................	62.00	62.00	57.00	52.00	52.00	52.00
“ 1065 Two or more procedures to which item 1063 applies (OP) ..................................	46.50	46.50	42.75	39.00	39.00	39.00
“ Blood Transfusion Procedures
“ 1080 Blood grouping (including back grouping when performed)—ABO and Rh (D antigen) (not covered by item 1089) (SP) ..........................................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1081 Blood grouping (including back grouping when performed)—ABO and Rh (D antigen) (not covered by item 1090) (OP) .........................................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1089 Blood grouping (including back grouping when performed)—ABO and Rh (D antigen) when performed in association with the compatibility testing covered by item 1112 or 1114 (SP) ..........................................................	11.20	11.20	10.40	9.40	9.40	9.40

Schedule—continued

“ 1090 Blood grouping (including back grouping when performed)—ABO and Rh (D antigen) when performed in association with the compatibility testing covered by item 1113 or 1116 (OP) .........................................................	8.40	8.40	7.80	7.05	7.05	7.05
“ 1101 Blood grouping—for Rh phenotypes or grouping by the Kell, Duffy or any other blood group system—one procedure (SP) .......................................

12.50	12.50	11.50	10.50	10.50	10.50
“ 1102 Blood grouping—for Rh phenotypes or grouping by the Kell, Duffy or any other blood group system—one procedure (OP) ......................................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1104 Two procedures to which item 1101 applies (SP)..............................................	25.00	25.00	23.00	21.00	21.00	21.00
“ 1105 Two procedures to which item 1102 applies (OP) ............................................	18.75	18.75	17.25	15.75	15.75	15.75
“ 1106 Each procedure to which item 1101 applies in excess of two (SP) ..............	6.20	6.20	5.70	5.20	5.20	5.20
“ 1108 Each procedure to which item 1102 applies in excess of two (OP) ..............	4.65	4.65	4.30	3.90	3.90	3.90
“ 1112 Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and don or group check where performed—testing involving one or two units of blood (SP)..............	25.00	25.00	23.00	21.00	21.00	21.00
“ 1113 Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—testing involving one or two units of blood (OP).............	18.75	18.75	17.25	15.75	15.75	15.75
“ 1114 Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—each unit of blood tested in excess of two (SP) .................	9.40	9.40	8.60	7.90	7.90	7.90
“ 1116 Compatibility testing (by saline, papain, albumin or indirect Coombs techniques), including auto-crossmatch and donor group check where performed—each unit of blood tested in excess of two (OP) ................	7.05	7.05	6.45	5.95	5.95	5.95
“ 1121 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) (SP) ..........................................................	9.40	9.40	8.60	7.90	7.90	7.90
“ 1122 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) (OP)...........................................................	7.05	7.05	6.45	5.95	5.95	5.95

Schedule—continued

“ 1124 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) and quantitative estimation of one antibody (SP) .........................................	25.00	25.00	23.00	21.00	21.00	21.00
“ 1125 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—screening test (including all indicated techniques) and quantitative estimation of one antibody (OP) .........................................	18.75	18.75	17.25	15.75	15.75	15.75
“ 1126 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of one antibody (SP) .........	18.80	18.80	17.20	15.80	15.80	15.80
“ 1128 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of one antibody (OP) .........	14.10	14.10	12.90	11.85	11.85	11.85
“ 1129 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of each antibody in excess of one (SP) ..............................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1130 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies—quantitative estimation of each antibody in excess of one (OP) .............................................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1136 Coombs test, direct (SP) ............................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1137 Coombs test, direct (OP) ...........................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1144 Coombs test, indirect (not associated with item 1112, 1114, 1121, 1124, 1126 or 1129, except where part of neo-natal screening or in investigation of haemolytic anaemia) (SP) ...............	9.40	9.40	8.60	7.90	7.90	7.90
“ 1145 Coombs test, indirect (not associated with item 1113, 1116, 1122,1125, 1128 or 1130, except where part of neo-natal screening or in investigation of haemolytic anaemia) (OP) ...............	7.05	7.05	6.45	5.95	5.95	5.95
“ 1152 Examination of serum for blood group haemolysins (SP) ...................................	12.50	12.50	11.50	10.50	10.50	10.50
“  1153 Examination of serum for blood group haemolysins (OP) ..................................	9.40	9.40	8.65	7.90	7.90	7.90
“1159 Leucocyte agglutinins, detection of (SP) .	12.50	12.50	11.50	10.50	10.50	10.50
“ 1160 Leucocyte agglutinins, detection of (OP).	9.40	9.40	8.65	7.90	7.90	7.90
“ 1166 Platelet agglutinins, detection of (SP) .....	12.50	12.50	11.50	10.50	10.50	10.50
“ 1167 Platelet agglutinins, detection of (OP)......	9.40	9.40	8.65	7.90	7.90	7.90

Schedule—continued

“ Miscellaneous

“ 1190 Heterophile antibodies—qualitative estimation of (test for infectious mononucleosis) (SP) ..............................	5.00	5.00	4.60	4.20	4.20	4.20
“ 1191 Heterophile antibodies—qualitative estimation of (test for infectious mononucleosis) (OP) .............................	3.75	3.75	3.45	3.15	3.15	3.15
“ 1194 Heterophile antibodies—quantitative estimation of by serial dilutions with specific absorption (including qualitative estimation covered by item 1190 where performed) (SP) ................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1195 Heterophile antibodies—quantitative estimation of by serial dilutions with specific absorption (including qualitative estimation covered by item 1391 where performed) (OP) ...............	9.40	9.40	8.65	7.90	7.90	7.90
“ 1202 Cold agglutinins, qualitative estimation of (SP) ......................................................	5.00	5.00	4.60	4.20	4.20	4.20
“ 1203 Cold agglutinins, qualitative estimation of (OP) ......................................................	3.75	3.75	3.45	3.15	3.15	3.15
“ 1206 Cold agglutinins, quantitative estimation of by serial dilutions (including qualitative estimation covered by item 1202 where performed) (SP) ................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1207 Cold agglutinins, quantitative estimation of by serial dilutions (including qualitative estimation covered by item 1203 where performed) (OP) ...............	9.40	9.40	8.65	7.90	7.90	7.90
“ 1211 Blood volume, estimation of by dye method (SP) .............................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1212 Blood volume, estimation of by dye method (OP) ............................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1215 Blood, spectroscopic examination of (SP)....................................................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1216 Blood, spectroscopic examination of (OP)............................................................	4.65	4.65	4.30	3.90	3.90	3.90
“Haemostasis
“ 1234 Estimation of—bleeding time, coagulation time (including clot retraction), prothrombin time (one stage) or thromboplastin time (partial) with or without kaolin or kaolin clotting time—one procedure (SP).......	6.20	6.20	5.70	5.20	5.20	5.20
“ 1235 Estimation of—bleeding time, coagulation time (including clot retraction), prothrombin time (one stage) or thromboplastin time (partial) with or without kaolin or kaolin clotting time—one procedure (OP) .....	4.65	4.65	4.30	3.90	3.90	3.90
“ 1236 Two procedures to which item 1234 applies (SP)...............................................	9.40	9.40	8.60	7.90	7.90	7.90
“ 1237 Two procedures to which item 1235 applies (OP) .............................................	7.05	7.05	6.45	5.95	5.95	5.95
“ 1238 Three or more procedures to which item 1234 applies (SP).....................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1239 Three or more procedures to which item. 1235 applies (OP) ...................................	9.40	9.40	8.65	7.90	7.90	7.90

Schedule—continued

“ 1242 Platelet aggregation, qualitative test for (SP) ............................................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1243 Platelet aggregation, qualitative test for (OP) ...........................................................	4.65	4.65	4.30	3.90	3.90	3.90
“1244 Estimation of thrombin time (including test for presence of an inhibitor and serial test for fibrinogenolysis) or recalcified plasma clotting time—each procedure (SP)..........................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1246 Estimation of thrombin time (including test for presence of an inhibitor and serial test for fibrinogenolysis) or recalcified plasma clotting time—each procedure (OP)..........................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1247 Fibrinogen titre, determination of (SP) ...	6.20	6.20	5.70	5.20	5.20	5.20
“ 1248 Fibrinogen titre, determination of (OP) ..	4.65	4.65	4.30	3.90	3.90	3.90
“ 1251 Factor 13, test for presence of (SP)...........	9.40	9.40	8.60	7.90	7.90	7.90
“ 1252 Factor 13, test for presence of (OP)..........	7.05	7.05	6.45	5.95	5.95	5.95
“ 1255 Thromboplastin generation screening test (SP) ............................................................	9.40	9.40	8.60	7.90	7.90	7.90
“ 1256 Thromboplastin generation screening test (OP).............................................................	7.05	7.05	6.45	5.95	5.95	5.95
“ 1259 Prothrombin time, estimation of (two stage) (SP) ................................................	9.40	9.40	8.60	7.90	7.90	7.90
“ 3260 Prothrombin time, estimation of (two stage) (OP).................................................	7.05	7.05	6.45	5.95	5.95	5.95
“ 1263 Quantitative estimation of—fibrin degeneration products, platelet adhesion, prothrombin consumption or protamine sulphate—each procedure (SP) ............................................................	9.40	9.40	8.60	7.90	7.90	7.90
“ 1264 Quantitative estimation of—fibrin degeneration products, platelet adhesion, prothrombin consumption or protamine sulphate—each procedure (OP).............................................................	7.05	7.05	6.45	5.95	5.95	5.95
“ 1267 Euglobulin lysis time, estimation of (SP)	18.80	18.80	17.20	35.80	15.80	15.80
“ 1268 Euglobulin lysis time, estimation of (OP)	14.10	14.10	32.90	11.85	11.85	11.85
“ 1271 Quantitative estimation of platelet antibodies (by one or more techniques), platelet Factor III availability or one or more blood coagulation factors (including antihaemophilic globulin)—each procedure (SP) ...............................	18.80	18.80	17.20	15.80	15.80	15.80
“ 1272 Quantitative estimation of platelet antibodies (by one or more techniques), platelet Factor III availability or one or more blood coagulation factors (including antihaemophilic globulin)—each procedure (OP) ...............................	14.10	14.10	12.90	11.85	11.85	11.85
“ 1277 Platelet aggregation test using ADP, collagen, 5HT, ristocetin, or a similar substance—one procedure (SP) ...........	18.80	18.80	17.20	15.80	15.80	35.80

Schedule—continued

“ 1278 Platelet aggregation test using ADP, collagen, 5HT, ristocetin, or a similar substance—one procedure (OP)............	14.10	14.10	12.90	11.85	11.85	11.85
“ 1279 Two or more procedures to which item 1277 applies (SP)......................................	37.50	37.50	34.50	31.50	31.50	31.50
“ 1280 Two or more procedures to which item 1278 applies (OP) ....................................	28.15	28.15	25.90	23.65	23.65	23.65
“Division 2—Chemistry of Body Fluids and Tissues
“ 1301 Estimation by any method of—albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct), bilirubin (indirect), calcium, chloride, cholesterol, CK, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than item 1302 where the estimation is performed on a multichannel analyser—one estimation (SP)...............	9.40	9.40	8.60	7.90	7.90	7.90
“ 1302 Estimation by any method of—albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct), bilirubin (indirect), calcium, chloride, cholesterol, CK, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than item 1301 where the estimation is performed on a multichannel analyser—one estimation (OP)...............	7.05	7.05	6.45	5.95	5.95	5.95
“ 1304 Two estimations of a kind specified in item 1301 (SP) .........................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1305 Two estimations of a kind specified in item 1302 (OP) .........................................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1306 Three to five estimations of a kind specified in item 1301 (SP) ...................	15.60	15.60	14.40	13.20	1.3.20	13.20
“ 1307 Three to five estimations of a kind specified in item 1302 (OP) ...................	11.70	11.70	10.80	9.90	9.90	9.90
“ 1309 Six or more estimations of a kind specified in item 1301 (SP) ...................	18.80	1.8.80	17.20	15.80	15.80	15.80
“ 1310 Six or more estimations of a kind specified in item 1302 (OP) ...................	14.10	14.10	12.90	11.85	11.85	11.85
“ 1319 Qualitative estimation of—acidity (by pH meter or titration), blood in faeces (occult blood), cryoglobulins, cryoproteins, euglobins, macroglobulins (Sia test), PBG, UBG or any other substance not specified in any other item in this Division—one estimation (SP) ........................................	3.10	3.10	2.90	2.60	2.60	2.60

Schedule—continued

“ 1320 Qualitative estimation of—acidity (by pH meter or titration), blood in faeces (occult blood), cryoglobulins, cryoproteins, euglobulins, macroglobulins (Sia test), PBG, UBG or any other substance not specified in any other item in this Division—one estimation (OP) .......................................	2.35	2.35	2.20	1.95	1.95	1.95
“ 1322 Two or more estimations to which item 1319 applies (SP) .....................................	6.20	6.20	5.70	5.20	5.20	5.20
“1323 Two or more estimations to which item 1320 applies (OP) ....................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1327 Qualitative estimation of—foetoprotein, gastric acidity (by dye method) or porphyrins—each estimation (SP) .......	12.50	12.50	11.50	10.50	10.50	10.50
“ 1328 Qualitative estimation of—foetoprotein, gastric acidity (by dye method) or porphyrins—each estimation (OP) .......	9.40	9.40	8.65	7.90	7.90	7.90
“ 1330 Chromatography, qualitative estimation of a substance not specified in any other item in this Division (SP) ............	12.50	12.50	11.50	10.50	50.50	10.50
“ 1331 Chromatography, qualitative estimation of a substance not specified in any other item in this Division (OP) ............	9.40	9.40	8.65	7.90	7.90	7.90
“ 1333 Electrophoresis, qualitative (SP) ..............	12.50	12.50	11.50	10.50	10.50	10.50
“  1334 Electrophoresis, qualitative (OP) ............	9.40	9.40	8.65	7.90	7.90	7.90
“ 1336 Australia antigen or similar antigen, detection of by any method including radioimmunoassay (SP) ..........................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1337 Australia antigen or similar antigen, detection of by any method including radioimmunoassay (OP) .........................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1339 Osmolality, estimation of in serum or urine (SP)  .................................................	12.50	12.50	11.50	10.50	10.50	10.50
“  1340 Osmolality, estimation of in serum or urine (OP) ................................................	9.40	9.40	8.65	7.90	7.90	7.90
“1342 Quantitative estimation of—acid phosphatase, aldolase, amylase, lipase, amylase and lipase, bromide, BSP, caeruloplasmin, carotene, complement fraction, any other specific protein (excluding immunoglobulins) (where estimated by immunodiffusion, nephelometry, Laurell rocket or similar technique), creatine, hexosamine, lactate, lithium, magnesium, pyruvate, salicylate or xylose—each estimation (SP)..............................................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1343 Quantitative estimation of—acid phosphatase, aldolase, amylase, lipase, amylase and lipase, bromide, BSP, caeruloplasmin, carotene, complement fraction, any other specific protein (excluding immunoglobulins) (where estimated by immunodiffusion,.............

 

Schedule—continued

nephelometry, Laurell rocket or similar technique), creatine, hexosamine, lactate, lithium, magnesium, pyruvate, salicylate or xylose—each estimation (OP).............................................................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1345 Quantitative estimation of—arsenic, copper, gold, lead, mercury, strontium, zinc, folic acid, vitamin B12, alcohol, ammonia, neo-natal bilirubin (direct and indirect), cholinesterase, coproporphyrin uroporphyrin, any other porphyrin factor, delta ALA, 5HIAA, iron (including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase or any substance not specified in any other item in this Division—each estimation (SP) ............................................................	18.80	18.80	17.20	15.80	15.80	55.80
“ 1346 Quantitative estimation of—arsenic, copper, gold, lead, mercury, strontium, zinc, folic acid, vitamin B12, alcohol, ammonia, neo-natal bilirubin (direct and indirect), cholinesterase, coproporphyrin, uroporphyrin, any other porphyrin factor, delta ALA, 5HIAA, iron (including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase or any substance not specified in any other item in this Division—each estimation (OP).............	14.10	14.10	12.90	11.85	11.85	11.83
“ 1348 Dibucaine number or similar, determination of (SP)  .............................	18.80	18,80	17.20	15.80	15.80	15.80
“ 1349 Dibucaine number or similar, determination of (OP)  ............................	14.10	14.10	12.90	13.85	11.85	11.85
“ 1351 Indican, qualitative test for (SP) ..............	18.80	18.80	17.20	15.80	15.80	15.80
“ 1352 Indican, qualitative test for (OP) ..............	14.10	14.10	12.90	11.85	11.85	11.85
“ 1354 Calculus, analysis of (SP) .........................	18.80	18.80	17.20	15.80	15.80	15.80
“ 1355 Calculus, analysis of (OP) .........................	14.10	14.10	12.90	11.85	11.85	11.85
“ 1357 Amniotic fluid, spectrophotometric analysis of (SP)  .......................................	18. 80	18.80	17.20	15.80	15.80	15.80
“ 1358 Amniotic fluid, spectrophotometric analysis of (OP)  ......................................	14.10	14.10	12.90	11.85	11.85	11.85
“ 1360 Electrophoresis, quantitative (including qualitative test) (SP) ................................	18.80	18.80	17.20	15.80	15.80	15.80
“ 1362 Electrophoresis, quantitative (including qualitative test) (OP) ...............................	14.10	14.10	12.90	11.85	11.85	11.85
“ 1364 Quantitative estimation of—catecholamines (each component), faecal fat, HMMA, hydroxyproline, blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH), non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction), or multiple steroid fractions estimated in the same process—each estimation (SP) .....................................................................	25.00	25.00	23.00	21.00	21.00	21.00

Schedule—continued

“ 1366 Quantitative estimation of—catecholamines (each component), faecal fat, HMMA, hydroxyproline, blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH), non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction), or multiple steroid fractions estimated in the same process—each estimation (OP )......................................

18.75	18.75	17.25	15.75	15.75	15.75
“ 1368 Chromatography, quantitative estimation (including qualitative test) of any substance not specified in any other item in this Division (SP) .....................	25.00	25.00	23.00	21.00	21.00	21.00
“ 1370 Chromatography, quantitative estimation (including qualitative test) of any substance not specified in any other item in this Division (OP) .....................	18.75	18.73	17.25	15.75	15.75	15.75
“ 1372 Lechithin/sphingomyelin ratio of amniotic fluid, determination of (SP) .	25.00	25.00	23.00	21.00	21.00	21.00
“ 1374 Lechithin/sphingomyelin ratio of amniotic fluid, determination of (OP)	18.75	18.75	17.25	15.75	15.75	15.75
“ 1376 Drug assays—qualitative estimations or screening procedures—one or more estimations or procedures on each specimen (SP) .........................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1378 Drug assays—qualitative estimations or screening procedures—one or more estimations or procedures on each specimen (OP) ........................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1380 Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin—estimation of one substance by one or more methods (SP) ...........................................................	15.60	15.60	14.40	13.20	13.20	13.20
“ 1381 Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin—estimation of one substance by one or more methods (OP) ..........................................................	11.70	11.70	10.80	9.90	9.90	9.90
“ 1382 Estimation of two substances referred to in item 1380 by using one or more of the methods specified in that item in relation to each (SP)  .............................	25.00	25.00	23.00	21.00	21.00	21.00
“ 1384 Estimation of two substances referred to in item 1381 by using one or more of the methods specified in that item in relation to each (OP)...............................	18.75	18.75	17.25	13.75	15.73	15.75

Schedule—continued

“ 1385 Estimation of three or more substances referred to in item 1380 by using one or more of the methods specified in that item in relation to each (SP)...........	31.00	33.00	28.50	26.00	26.00	26.00
“  1387 Estimation of three or more substances referred to in item 1381 by using one or more of the methods specified in that item in relation to each (OP) ........	23.25	23.25	21.40	19.50	19.50	19.50
“1392 Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of diazepam, ethosuximide, methotrexate, morphine, procainamide, quinidine or a similar substance not referred to in any item in this Division other than this item and item 1393—estimation of one substance by one or more methods (SP) ...........................................................	18.80	18.80	17.20	15.80	15.80	15.80
“ 1393 Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of diazepam, ethosuximide, methotrexate, morphine, procainamide, quinidine or a similar substance not referred to in any item in this Division other than this item and item 1392—estimation of one substance by one or more methods (OP)............................................................	14.10	14.10	12.90	11.85	11.85	11.85
“ 1394 Estimation of two substances referred to in item 1392 by using one or more of the methods specified in that item in relation to each (SP) ..............................	31.00	31.00	28.50	26.00	26.00	26.00
“ 1395 Estimation of two substances referred to in item 1393 by using one or more of the methods specified in that item in relation to each (OP) ..............................	23.25	23.25	23.40	19.50	19.50	19.50
“ 1397 Estimation of three or more substances referred to in item 1392 by using one or more of the methods specified in that item in relation to each (SP) .........	37.50	37.50	34.50	31.50	31.50	31.50
“ 1398 Estimation of three or more substances referred to in item 1393 by using one or more of the methods specified in that item in relation to each (OP)..........	28.15	28.15	25.90	23.65	23.65	23.65
“ Hormone Assays not covered by any other item in this Division
“ 1419 Assay of thyroxine (T4) or T3 resin uptake (or equivalent function test)—using any technique (SP)........................	9.40	9.40	8.60	7.90	7.90	7.90
“ 1420 Assay of thyroxine (T4) or T3 resin uptake (or equivalent function test)—using any technique (OP).......................	7.05	7.05	6.45	5.95	5.95	5.95
“ 1427 Assay of thyroxine (T4) and T3 resin uptake (or equivalent function test)—using any technique (SP) ......................	15.60	15.60	14.40	13.20	13.20	13.20

Schedule—continued

“ 1428 Assay of thyroxine (T4) and T3 resin uptake (or equivalent function test)—using any technique (OP) ......................	11.70	11.70	10.80	9.90	9.90	9.90
“ 1434 Assay of normalised thyroxine (effective thyroxine ratio) or similar assay—when not associated with a procedure to which item 1419 or 1427 applies—assay using any technique (SP).............	12.50	12.50	11.50	10.50	10.50	10.50
“ 1435 Assay of normalised thyroxine (effective thyroxine ratio) or similar assay—when not associated with a procedure to which item 1420 or 1428 applies—assay using any technique (OP)............	9.40	9.40	8.65	7.90	7.90	7.90
“ 1441 Assay of thyroxine (T4), T3 resin uptake (or equivalent function test) and normalised thyroxine (effective thyroxine ratio) or similar assay performed by a different procedure—assay using any technique (SP) ..........	22.00	22.00	20.00	18.40	18.40	18.40
“ 1442 Assay of thyroxine (T4), T3 resin uptake (or equivalent function test) and normalised thyroxine (effective thyroxine ratio) or similar assay performed by a different procedure—assay using any technique (OP) ...........	16.50	16.50	15.00	13.80	13.80	13.80
“ 1452 Hormone assays using gamma emitting labels or any other unspecified technique (excluding thyroid hormones covered by items 1419, 1427, 1434 and 1441)—one estimation of any one hormone (SP) ..........................................	18.80	18.80	17.20	15.80	15.80	15.80
“ 1453 Hormone assays using gamma emitting labels or any other unspecified technique (excluding thyroid hormones covered by items 1420, 1428, 1435 and 1442)—one estimation of any one hormone (OP) .........................................	14.10	14.10	12.90	11.85	11.85	11.85
“ 1455 Two estimations of any one hormone using any technique referred to in item 1452 (SP)...................................................	28.00	28.00	26.00	23.50	23.50	23.50
“ 1456 Two estimations of any one hormone using any technique referred to in item 1453 (OP)..................................................	21.00	21.00	19.50	17.65	17.65	17.65
“ 1458 Three estimations of any one hormone using any technique referred to in item 1452 (SP)...................................................	37.50	37.50	34.50	31.50	31.50	31.50
“ 1459 Three estimations of any one hormone using any technique referred to in item 1453 (OP)..................................................	28.15	28.15	25.90	23.65	23.65	23.65
1461 Each estimation of any one hormone in excess of three estimations using any technique referred to in item 1452 (SP)	3.70	3.70	3.40	3.10	3.10	3.10
“ 1462 Each estimation of any one hormone in excess of three estimations using any technique referred to in item 1453 (OP) ..........................................................	2.80	2.80	2.55	2.35	2.35	2.35

Schedule—continued

“ 1475 Hormone assay using beta emitting labels or bioassay techniques—one estimation of any one hormone (SP) ..	31.00	31.00	28.50	26.00	26.00	26.00
“ 1476 Hormone assay using beta emitting labels or bioassay techniques—one estimation of any one hormone (OP) ..	23.25	23.25	21.40	19.50	19.50	19.50
“ 1478 Hormone assays using beta emitting labels or bioassay techniques—two estimations of any one hormone (SP) .	50.00	50.00	46.00	42.00	42.00	42.00
“ 1479 Hormone assays using beta emitting labels or bioassay techniques—two estimations of any one hormone (OP)..	37.50	37.50	34.50	31.50	31.50	31.50
“ 1481 Hormone assays using beta emitting labels or bioassay techniques—three estimations of any one hormone (SP) .	62.00	62.00	57.00	52.00	52.00	52.00
“ 1482 Hormone assays using beta emitting labels or bioassay techniques—three estimations of any one hormone (OP)	46.50	46.50	42.75	39.00	39.00	39.00
“ 1484 Hormone assays using beta emitting labels or bioassay techniques—each estimation of any one hormone in excess of three (SP).................................	6.20	6.20	5.70	5.20	5.20	5.20
“  1485 Hormone assays using beta emitting labels or bioassay techniques—each estimation of any one hormone in excess of three (OP)................................	4.65	4.65	4.30	3.90	3.90	3.90
“ Procedural Services
“ 1504 Procedural services associated with—ACTH stimulation test, adrenaline tolerance test, arginine infusion test, bromsulphthalein test, carbohydrate tolerance test, creatinine clearance test, gastric function test requiring intubation, glucagon tolerance test, histidine loaded FIGLU test, 1-dopa stimulation test, phenolsulphthalein excretion test, TSH stimulation test (other than the administration of TSH), urea clearance test, urea concentration test, vasopressin stimulation lest, xylose absorption test, or any similar test (SP).....................................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1505 Procedural services associated with—ACTH stimulation test, adrenaline tolerance test, arginine infusion test, bromsulphthalein test, carbohydrate tolerance test, creatinine clearance test, gastric function test requiring intubation, glucagon tolerance test, histidine loaded FIGLU test, 1-dopa stimulation test, phenolsuphthalein excretion test, TSH stimulation test (other than the administration of TSH), urea clearance test, urea concentration test, vasopressin stimulation test, xylose absorption test, or any similar test (OP) ...................................................	4.65	4.65	4.30	3.90	3.90	3.90

Schedule—continued

“ 1511 Procedural services associated with—tolbutamide test, insulin hypoglycaemia stimulation test, gonadotrophin releasing hormone stimulation test (other than the administration of gonadotrophin releasing hormone), thyrotrophin releasing hormone stimulation test (other than the administration of thyroid stimulating hormone), urine acidification test, or any similar test (SP).............................................................	18.80	18.80	17.20	15.80	15.80	15.80
“ 1512 Procedural services associated with—tolbutamide test, insulin hypoglycaemia stimulation test, gonadotrophin releasing hormone stimulation test (other than the administration of gonadotrophin releasing hormone), thyrotropin releasing hormone stimulation test (other than the administration of thyroid stimulating hormone), urine acidification test, or any similar test (OP) ..........................................................	14.10	14.10	12.90	11.85	11.85	11.85
“  1516 Procedural services associated with the administration of—thyrotrophin releasing hormone, gonadotrophin releasing hormone or thyroid stimulating hormone (SP)......................	15.60	15.60	14.40	13.20	13.20	13.20
“1517 Procedural services associated with the administration of—thyrotrophin releasing hormone, gonadotrophin releasing, hormone or thyroid stimulating hormone (OP)......................	11.70	11.70	10.80	9.90	9.90	9.90
“Division 3—Microbiology
“ 1529 Microscopical examination, wet film, not covered by item 1536 (SP) ...................	3.70	3.70	3.40	3.10	3.10	3.10
“ 1530 Microscopical examination, wet film, not covered by item 1537 (OP) ..................	2.80	2.80	2.55	2.35	2.35	2.35
“ 1536 Microscopical examination of urine and examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (SP) ..........................................	5.00	5.00	4.60	4.20	4.20	4.20
“ 1537 Microscopical examination of urine and examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (where the patient is referred by another medical practitioner) (OP)	3.75	3.75	3.45	3.15	3.15	3.15
“ 1545 Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)—one stain (SP) ............	5.00	5.00	4.60	4.20	4.20	4.20
“ 1546 Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)—one stain (OP) ............	3.75	3.75	3.45	3.15	3.15	3.15
“ 1548 Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)—two or more stains (SP) ...........................................................	6.20	6.20	5.70	5.20	5.20	5.20

Schedule—continued

“ 3549 Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)—two or more stains (OP) ..........................................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1556 Microscopical examination using special stain (e.g. Ziehl-Neelsen or similar stain)—one stain (SP).............................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1557 Microscopical examination using special stain (e.g. Ziehl-Neelsen or similar stain)—one stain (OP).............................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1566 Microscopical examination using two or more stains, one or more of which is a special stain referred to in item 1556 (SP)   ..........................................................	9.40	9.40	8.60	7.90	7.90	7.90
“ 1567 Microscopical examination using two or more stains, one or more of which is a special stain referred to in item 1557 (OP)   .........................................................	7.05	7.05	6.45	5.95	5.95	5.95
“ 1586 Microscopical examination for dermatophytes—examination of material from one site (SP) ...................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1587 Microscopical examination for dermatophytes—examination of material from one site (OP) ..................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1588 Microscopical examination for dermatophytes—examination of material from two or more sites (SP)...	12.50	12.50	11.50	10.50	10.50	10.50
“ 1589 Microscopical examination for dermatophytes—examination of material from two or more sites (OP) .	9.40	9.40	8.65	7.90	7.90	7.90
“ 1604 Microscopical examination of exudate by dark ground illumination for Treponema pallidum (SP) .....................	15.60	15.60	14.40	13.20	13.20	13.20
“ 1606 Microscopical examination of exudate by dark ground illumination for Treponema pallidum (OP) ....................	11.70	11.70	10.80	9.90	9.90	9.90
“ 1609 Cultural examination of a specimen other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures (SP) ......................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1610 Cultural examination of a specimen other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures (OP)............................................................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1615 Cultural examination of a specimen other than blood or urine for aerobic and anaerobic microorganisms using anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures (SP) ........	18.80	18.80	17.20	15.80	15.80	15.80

24486/75—17

Schedule—continued

“ 1616 Cultural examination of a specimen other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures (OP) ............	14.10	14.10	12.90	11.85	11.85	11.85
“ 1622 Cultural examination for mycobacteria—each specimen (SP) ................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1623 Cultural examination for mycobacteria—each specimen (OP) ...............................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1633 Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification—each set of cultures to a maximum of three sets (SP) .................	18.80	18.80	17.20	15.80	15.80	15.80
“ 1634 Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification—each set of cultures to a maximum of three sets (OP) ................	14.10	14.10	12.90	11.85	11.85	11.85
“ 1644 Identification of pathogenic microorganisms using biochemical tests or other special techniques involving sub-culture or biochemical tests and other special techniques involving sub-culture—identification of one organism (SP) .............................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1645 Identification of pathogenic microorganisms using biochemical tests or other special techniques involving sub-culture or biochemical tests and other special techniques involving sub-culture—identification of one organism (OP) ............................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1647 Identification of two or more organisms by the method referred to in item 1644 (SP)  ..........................................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1648 Identification of two or more organisms by the method referred to in item 1645 (OP)............................................................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1661 Identification of pathogenic micro-organsims using a serological technique (including the immunofluorescent or immunoenzymic method)—a procedure involving one technique (SP) ...........................................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1662 Identification of pathogenic microorganisms using a serological technique (including the immunofluorescent or immunoenzymic method)—a procedure involving one technique (OP)............................................................	4.65	4.65	4.30	3.90	3.90	3.90

Schedule—continued

“ 1664 Two or more of any procedures of a kind referred to in item 1661 using different techniques (SP) .......................................	9.40	9.40	8.60	7.90	7.90	7.90
“ 1665 Two or more of any procedures of a kind referred to in item 1662 using different techniques (OP) ......................................	7.05	7.05	6.45	5.95	5.95	5.95
“ 1673 Microscopical examination of urine, with cell count, relevant stains (if indicated), cultural examination and colony count of microorganisms (not being a service to which item 1682 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (SP) ..........................................	17.40	17.40	16.00	14.60	14.60	14.60
“ 1674 Microscopical examination of urine, with cell count, relevant stains (if indicated), cultural examination and colony count of microorganisms (not being a service to which item 168.1 applies), with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (OP) ...........	13.05	13.05	12.00	10.95	10.95	10.95
“ 1682 Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (SP) .................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1683 Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (where the patient is referred by another medical practitioner) (OP) ...................................

4.65	4.65	4.30	3.90	3.90	3.90
“ 1687 Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (SP) .............	9.40	9.40	8.60	7.90	7.90	7.90
“ 1688 Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (OP)..............	7.05	7.05	6.45	5.95	5.95	5.95
“ 1693 Identification of helminths (SP) ...............	6.20	6.20	5.70	5.20	5.20	5.20
“ 1694 Identification of helminths (OP) ..............	4.65	4.65	4.30	3.90	3.90	3.90
“ 1702 Cultural examination for parasites, other than trichomonas—culture of one parasite (SP) ............................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1703 Cultural examination for parasites, other than trichomonas—culture of one parasite (OP) ...........................................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1705 Cultural examination for parasites, other than trichomonas—culture of two or more parasites (SP) ................................	22.00	22.00	20.00	18.40	18.40	18.40
“ 1706 Cultural examination for parasites, other than trichomonas—culture of two or more parasites (OP) ...............................	16.50	16.50	15.00	13.80	13.80	13.80

Schedule—continued

“ 1712 Examination by animal inoculation (SP)	25.00	25.00	23.00	21.00	21.00	21.00
“ 1713 Examination by animal inoculation (OP)	18.75	18.75	17.25	15.75	15.75	15.75
“ 1721 Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique—one organism (SP) ............	12.50	12.50	11.50	10.50	10.50	10.50
“ 1722 Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique—one organism (OP) ...........	9.40	9.40	8.65	7.90	7.90	7.90
“ 1724 Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique—two or more organisms (SP) ...........................................................	15.60	15.60	14.40	13.20	13.20	13.20
“ 1725 Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique—two or more organisms (OP) ..........................................................	11.70	11.70	10.80	9.90	9.90	9.90
“ 1732 Detection of substances inhibitory to micro-organisms in a body fluid (including urine) (SP).............................	3.10	3.10	2.90	2.60	2.60	2.60
“ 1733 Detection of substances inhibitory to micro-organisms in a body fluid (including urine) (OP).............................	2.35	2.35	2.20	1.95	1.95	1.95
“ 1743 Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (SP).............................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1744 Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (OP).............................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1760 Agglutination tests (quantitative), including those for enteric fever and brucellosis—one antigen (SP)...............	9.40	9.40	8.60	7.90	7.90	7.90
“ 1761 Agglutination tests (quantitative), including those for enteric fever and brucellosis—one antigen (OP) .............	7.05	7.05	6.45	5.95	5.95	5.95
“ 1763 Agglutination tests (quantitative), including those for enteric fever and brucellosis—second to sixth antigen—each antigen (SP) ...................................	5.00	5.00	4.60	4.20	4.20	4.20
“ 1764 Agglutination tests (quantitative), including those for enteric fever and brucellosis—second to sixth antigen—each antigen (OP) ...................................	3.75	3.75	3.45	3.15	3.15	3.15
“ 1766 Agglutination tests (quantitative), including those for enteric fever and brucellosis—each antigen in excess of six (SP) .....................................................	2.50	2.50	2.30	2.10	2.10	2.10
“ 1767 Agglutination tests (quantitative), including those for enteric fever and brucellosis—each antigen in excess of sis (OP) ....................................................	1.90	1.90	1.75	1.60	1.60	1.60
“ 1772 Flocculation test, including V.D.R.L., Kahn, Kline or similar tests—one test (SP) ...........................................................	3.1.0	3.10	2.90	2.60	2.60	2.60

Schedule—continued

“ 1773 Flocculation test, including V.D.R.L., Kahn, Kline or similar tests—one test (OP) ..........................................................	2.35	2.35	2.20	1.95	1.95	1.95
“ 1775 Flocculation tests, including V.D.R.L., Kahn, Kline or similar tests—two or more tests (SP) ........................................	3.70	3.70	3.40	3.10	3.10	3.10
“ 1776 Flocculation tests, including V.D.R.L., Kahn, Kline or similar tests—two or more tests (OP) .......................................	2.80	2.80	2.55	2.35	2.35	2.35
“ 1781 Complement fixation tests—one test (SP)....................................................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1782 Complement fixation tests—one test (OP)	9.40	9.40	8.65	7.90	7.90	7.90
“ 1784 Complement fixation, tests—each test in excess of one (SP) ..................................	3.10	3.10	2.90	2.60	2.60	2.60
“ 1785 Complement fixation tests—each test in excess of one (OP) .................................	2.35	2.35	2.20	1.95	1.95	1.95
“ 1793 Fluorescent serum antibody test (FTA test, FTA—absorbed test or similar)—one test (SP) ............................................	9.40	9.40	8.60	7.90	7.90	7.90
“ 1794 Fluorescent serum antibody test (FTA test, FTA—absorbed test or similar)—one test (OP) ...........................................	7.05	7.05	6.45	5.95	5.95	5.95
“ 1796 Each test referred to in item 1793 in excess of one (SP) ..................................	5.00	5.00	4.60	4.20	4.20	4.20
“ 1797 Each test referred to in item 1794 in excess of one (OP)...................................	3.75	3.75	3.45	3.15	3.15	3.15
“  1805 Haemagglutination tests—one test (SP)	6.20	6.20	5.70	5.20	5.20	5.20
“1806 Haemagglutination tests—one test (OP).	4.65	4.65	4.30	3.90	3.90	3.90
“ 1808 Haemagglutination tests—each test in excess of one (SP) ..................................	3.10	3.10	2.90	2.60	2.60	2.60
“1809 Haemagglutination tests—each test in excess of one (OP)...................................	2.35	2.35	2.20	1.95	1.95	1.95
“ 1823 Haemagglutination inhibition tests—one test (SP) ....................................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1824 Haemagglutination inhibition tests—one test (OP).....................................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1826 Haemagglutination inhibition tests—each test in excess of one (SP) ......................	3.10	3.10	2.90	2.60	2.60	2.60
“ 1827 Haemagglutination inhibition tests—each test in excess of one (OP) .....................	2.35	2.35	2.20	1.95	1.95	1.95
“ 1843 Antistreptolysin 0 titre test (SP) ...............	9.40	9.40	8.60	7.90	7.90	7.90
“ 1844 Antistreptolysin 0 titre test (OP) ..............	7.05	7.05	6.45	5.95	5.95	5.95
“ 1851 Total and differential cell count on any body fluid other than: urine (SP) .........	6.20	6.20	5.70	5.20	5.20	5.20
“ 1852 Total and differential cell count on any body fluid other than urine (OP) .........	4.65	4.65	4.30	3.90	3.90	3.90
“ 1858 Autogenous vaccine, preparation of—each organism (SP) ................................	25.00	25.00	23.00	21.00	21.00	21.00
“ 1859 Autogenous vaccine, preparation of—each organism (OP) ...............................	18.75	18.75	17.25	15.75	15.75	15.75

Schedule—continued

“ Division 4—Immunology

“ 1877 Immunoelectrophoresis using polyvalent antisera (SP) ............................................	18.80	18.80	17.20	15.80	15.80	15.80
“ 1878 Immunoelectrophoresis using polyvalent antisera (OP) ...........................................	14.10	14.10	12.90	11.85	11.85	11.85
“ 1884 Immunoelectrophoresis using monovalent antiserum—each antiserum (SP) ........................................	3.10	3.10	2.90	2.60	2.60	2.60
“ 1885 Immunoelectrophoresis using monovalent antiserum—each antiserum (OP).........................................	2.35	2.35	2.20	1.95	1.95	1.95
“  1888 Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method—estimation of one immunoglobulin (SP)..............................	12.50	12.50	11.50	10.50	10.50	10.50
“1889 Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method—estimation of one immunoglobulin (OP) ...........................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1891 Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method—estimation of each immunoglobulin in excess of one (SP)	6.20	6.20	5.70	5.20	5.20	5.20
“ 1892 Immunoglobulins G, A, M or D, quantitative estimation of, by immunodiffusion or any other method—estimation of each immunoglobulin in excess of one (OP)	4.65	4.65	4.30	3.90	3.90	3.90
“ 3897 Immunoglobulin E, quantitative estimation, of (SP) .................................	18.80	18.80	17.20	15.80	15.80	15.80
“ 1898 Immunoglobulin E, quantitative estimation of (OP) ..................................	14.10	14.10	12.90	11.85	11.85	11.85
“ 1903 Radioallergosorbent tests for allergen identification—identification of one to four allergens—each allergen (SP) .....	6.20	6.20	5.70	5.20	5.20	5.20
“ 1904 Radioallergosorbent tests for allergen identification—identification of one to four allergens—each allergen (OP) ....	4.65	4.65	4.30	3.90	3.90	3.90
“ 1905 Radioallergosorbent tests for allergen identification—identification of each allergen in excess of four (SP) .............	3.10	3.10	2.90	2.60	2.60	2.60
“ 3906 Radioallergosorbent tests for allergen identification—identification of each allergen in excess of four (OP) ............	2.35	2.35	2.20	1.95	1.95	1.95
“ 1911 Immunofluorescent detection of tissue antibodies qualitative (not associated with the service specified in item 1918), detection of one antibody (SP)	12.50	12.50	11.50	10.50	10.50	10.50
“ 1912 Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in item 1919) detection of one antibody (OP)	9.40	9.40	8.65	7.90	7.90	7.90

Schedule—continued

“ 1913 Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in item 1918), detection of each antibody in excess of one (SP)....................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1914 Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in item 1919) detection of each antibody in excess of one (OP) .................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1918 Immunofluorescent detection of tissue antibodies, qualitative and quantitative—detection and estimation of each antibody (SP)..............................	15.60	15.60	14.40	13.20	13.20	13.20
“ 1919 Immunofluorescent detection; of tissue antibodies, qualitative and quantitative—detection and examination of each antibody (OP) ....	11.70	11.70	10.80	9.90	9.90	9.90
“ 1924 Complement fixation tests on human tissue antibodies—one antibody (SP) .	12.50	12.50	11.50	10.50	10.50	10.50
“ 1925 Complement fixation tests on human tissue antibodies—one antibody (OP)	9.40	9.40	8.65	7.90	7.90	7.90
“ 1926 Complement fixation tests on human tissue antibodies—each antibody in excess of one (SP) ..................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1927 Complement fixation tests on human tissue antibodies—each antibody in excess of one (OP) .................................	4.65	4.65	4.30	3.90	3.90	3.90
“  1935 Latex flocculation test—qualitative, quantitative or qualitative and quantitative (SP) .....................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 1936 Latex flocculation test—qualitative, quantitative or qualitative and quantitative (OP) ....................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 1941 Rose Waaler test, quantitative, using sheep cells (SP) ......................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1942 Rose Waaler test, quantitative, using sheep cells (OP).......................................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1948 Lupus erythematosus cells, preparation and examination of film for (SP) .........	9.40	9.40	8.60	7.90	7.90	7.90
“ 1949 Lupus erythematosus cells, preparation and examination of film for (OP) ........	7.05	7.05	6.45	5.95	5.95	5.95
“ 1955 Tanned erythrocyte haemagglutination test for tissue antibodies—one antibody (SP) ..........................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 1956 Tanned erythrocyte haemagglutination test for tissue antibodies—one antibody (OP) ..........................................	9.40	9.40	8.65	7.90	7.90	7.90
“ 1957 Tanned erythrocyte haemogglutination test for tissue antibodies—each antibody in excess of one (SP)..............	6.20	6.20	5.70	5.20	5.20	5.20
“ 1958 Tanned erythrocyte haemaggultination test for tissue antibodies—each antibody in excess of one (OP) ............	4.65	4.65	4.30	3.90	3.90	3.90

Schedule—continued

“ 1965 Leucocyte fractionation as preliminary test to specific tests of leucocyte function—by density gradient centrifugation or any other method (SP).............................................................	18.80	18.80	17.20	15.80	15.80	15.80
“ 1966 Leucocyte fractionation as preliminary test to specific tests of leucocyte function—by density gradient centrifugation or any other method (OP)............................................................	14.10	14.10	12.90	11.85	11.85	11.85
“ 1971 Neutrophil function tests for phagocytic activity—visual techniques (SP)	18.80	18.80	17.20	15.80	15.80	15.80
“ 1972 Neutrophil function tests for phagocytic activity—visual techniques (OP) .........	14.10	14.10	12.90	11.85	11.85	11.85
“ 1973 Neutrophil function tests for phagocytic activity—radioactive techniques (SP)	31.00	31.00	28.50	26.00	26.00	26.00
“ 1974 Neutrophil function tests for phagocytic activity—radioactive techniques (OP).	23.25	23.25	21.40	19.50	19.50	19.50
“ 1981 Lymphocyte cell count—E rosette technique or similar (SP)........................	25.00	25.00	23.00	21.00	21.00	21.00
“ 1982 Lymphocyte cell count—E rosette technique or similar (OP).......................	18.75	18.75	17.25	35.75	15.75	15.75
“ 1987 B lymphocyte ceil count—by immunofluorescence or immunoperoxidase (SP) ........................	25.00	25.00	23.00	21.00	21.00	21.00
“ 1988 B lymphocyte cell count—by immunofluorescence or immunoperoxidase (OP) .......................	18.75	18.75	17.25	15.75	15.75	15.75
“ 1995 Lymphocyte function test—visual transformation (SP) ................................	25.00	25.00	23.00	21.00	21.00	21.00
“ 1996 Lymphocyte function test—visual transformation (OP) ...............................	18.75	18.75	17.25	15.75	15.75	15.75
“ 1997 Lymphocyte function test—radioactive techniques (SP) .......................................	37.50	37.50	34.50	31.50	31.50	31.50
“ 1998 Lymphocyte function test—radioactive techniques (OP) ......................................	28.15	28.15	25.90	23.65	23.65	23.65
“ 2006 Tissue group typing (HLA phenotyping) (SP) ...........................................................	31.00	31.00	28.50	26.00	26.00	26.00
“ 2007 Tissue group typing (HLA phenotyping) (OP)............................................................	23.25	23.25	21.40	19.50	19.50	19.50
“ 2013 Skin sensitivity testing (Mantoux, Schick, Casoni or similar test)—each test (SP)	6.20	6.20	5.70	5.20	5.20	5.20
“ 2014 Skin sensitivity testing (Mantoux, Schick, Casoni or similar test)—each test (OP)....................................................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 2022 Skin sensitivity—induction and detection of sensitivity to chemical antigens (SP)	12.50	12.50	11.50	10.50	10.50	10.50
“ 2023 Skin sensitivity—induction and detection of sensitivity to chemical antigens (OP) ..........................................................	9.40	9.40	8.65	7.90	7.90	7.90
“ Division 5—Histopathology
“ 2041 Histopathology examination of biopsy material—processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (SP) ............................................	43.50	43.50	40.00	36.50	36.50	36.50

Schedule—continued

“ 2042 Histopathology examination of biopsy material—processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (OP) ............................................	32.65	32.65	30.00	27.40	27.40	27.40
“ 2048 Immediate frozen section diagnosis of biopsy material performed at the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP) ................................................	56.00	56.00	52.00	47.00	47.00	47.00
“ 2049 Immediate frozen section diagnosis of biopsy material performed at the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP) ...............................................	42.00	42.00	39.00	35.25	35.25	35.25
“ 2056 Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP) ................................................	81.00	81.00	75.00	68.00	68.00	68.00
“ 2057 Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist’s laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP) ...............................................	60.75	60.75	56.25	51.00	51.00	51.00
“ Division 6—Cytology
“ 2081 Cytological examination for pathological change of smears from cervix and vagina, skin or mucous membrane—each examination (SP) ...........................	9.40	9.40	8.60	7.90	7.90	7.90
“ 2082 Cytological examination for pathological change of smears from cervix and vagina, skin of mucous membrane—each examination (OP) ..........................	7.05	7.05	6.45	5.95	5.95	5.95
“ 2091 Cytological examination for malignant cells—examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid or any similar fluid—each examination (SP) ..............	18.80	18.80	17.20	15.80	15.80	15.80
“ 2092 Cytological examination for malignant cells—examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid or any similar fluid—each examination (OP) .............	14.10	14.10	12.90	11.85	11.85	11.85
“ 2096 Cytological examination for malignant cells—examination of gastric washings, duodenal washings, oesophageal washings or colonic washings—each examination (SP) ......	25.00	25.00	23.00	21.00	21.00	21.00

Schedule—continued

“ 2097 Cytological examination for malignant cells—examination of gastric washings, duodenal washings, oesophageal washings or colonic washings—each examination (OP) .....	38.75	18.75	17.25	15.75	15.75	15.75
“ 2104 Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP) ...........................................................	9.40	9.40	8.60	7.90	7.90	7.90
“ 2105 Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP) ..........................................................	7.05	7.05	6.45	5.9	5.95	5.95
“ 2111 Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP)...............................................	15.60	15.60	14.40	13.20	13.20	13.20
“ 2112 Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP)..............................................	11.70	11.70	10.80	9.90	9.90	9.90
“ Division 7—Cytogenetics
“ 2131 Cytological sex determination from blood film (SP)....................................................

6.20	6.20	5.70	5.20	5.20	5.20
“ 2132 Cytological sex determination from blood film (OP)...................................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 2141 Cytological sex chromatin studies (Barr or Y bodies)—other than from blood film—each tissue examined (SP) ........	6.20	6.20	5.70	5.20	5.20	5.20
“ 2142 Cytological sex chromatin studies (Barr or Y bodies)—other than from blood film—each tissue examined (OP) .......	4.65	4.65	4.30	3.90	3.90	3.90
“ 2148 Chromosome studies, including preparation, count and karyotyping of amniotic fluid (SP)..................................	94.00	94.00	86.00	79.00	79.00	79.00
“ 2149 Chromosome studies, including preparation, count and karyotyping of amniotic fluid (OP) ................................	70.50	70.50	64.50	59.25	59.25	59.25
“ 2155 Chromosome studies, including preparation, count and karyotyping of bone marrow (SP) ..................................	62.00	62.00	57.00	52.00	52.00	52.00
“ 2156 Chromosome studies, including preparation, count and karyotyping of bone marrow (OP) ..................................	46.50	46.50	42.75	39.00	39.00	39.00
“ 2161 Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in item 2148 or 2155—each study (SP) ................................................	75.00	75.00	69.00	63.00	63.00	63.00
“ 2162 Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in item 2149 or 2156—each study (OP) ...............................................	56.25	56.25	51.75	47.25	47.25	47.25

Schedule—continued

“ 2170 Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—one method (SP).............................................................	62.00	62.00	57.00	52.00	52.00	52.00
“ 2171 Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—one method (OP) ..........................................................	46.50	46.50	42.75	39.00	39.00	39.00
“ 2173 Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—two or more methods (SP) ...........................................	94.00	94.00	86.00	79.00	79.00	79.00
“ 2174 Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)—two or more methods (OP)............................................	70.50	70.50	64.50	59.25	59.25	59.25
“Division 8—Infertility and Pregnancy Tests
“ 2201 Examination of semen for presence of spermatozoa (SP) ...................................	3.70	3.70	3.40	3.10	3.10	3.10
“ 2202 Examination of semen for presence of spermatozoa (OP) ...................................	2.80	2.80	2.55	2.35	2.35	2.35
“ 2211 Huhner’s test (post-coital test)—collection of sample and examination of wet preparation (SP) .........................	12.50	12.50	11.50	10.50	10.50	10.50
“ 2212 Huhner’s test (post-coital test)—collection of sample and examination of wet preparation (OP) ........................	9.40	9.40	8.65	7.90	7.90	7.90
“ 2215 Examination of semen involving measurement of volume, sperm count, gram or similar stain morphology by differential count and motility (including duration) or viability or both (SP) ..................................................	18.80	18.80	17.20	15.80	15.80	15.80
“ 2216 Examination of semen involving measurement of volume, sperm count, gram or similar stain, morphology by differential count and motility (including duration) or viability or both (OP)...................................................	14.10	14.10	12.90	11.85	11.85	11.85
“ 2225 Chemical analysis of semen—analysis of one substance (SP) .................................	9.40	9.40	8.60	7.90	7.90	7.90
“ 2226 Chemical analysis of semen—analysis of one substance (OP)..................................	7.05	7.05	6.45	5.95	5.95	5.95
“ 2227 Chemical analysis of semen—analysis of two or more substances (SP).................	15.60	15.60	14.40	13.20	13.20	13.20
“ 2228 Chemical analysis of semen—analysis of two or more substances (OP) ...............	11.70	11.70	10.80	9.90	9.90	9.90
“ 2247 Spermagglutinating and immobilising antibodies, test for—one test (SP) ......	9.40	9.40	8.60	7.90	7.90	7.90
“ 2248 Sperm agglutinating and immobilising antibodies, test for—one test (OP) ......	7.05	7.05	6.45	5.95	5.95	5.95
“  2249 Two or more tests referred to in item 2247 (SP)...................................................	12.50	12.50	11.50	10.50	10.50	10.50
“ 2250 Two or more tests referred to in item 2248 (OP) ................................................	9.40	9.40	8.65	7.90	7.90	7.90
“ 2264 Sperm penetrability, one or more tests for (SP).............................................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 2265 Sperm penetrability, one or more tests for (OP)............................................................	4.65	4.65	4.30	3.90	3.90	3.90

Schedule—continued

“ 2272 Chorionic gonadotrophin, qualitative estimation of for diagnosis of pregnancy or hormone—producing neoplasm by one or more methods (SP).............................................................	6.20	6.20	5.70	5.20	5.20	5.20
“ 2273 Chorionic gonadotrophin, qualitative estimation of for diagnosis of pregnancy or hormone—producing neoplasm by one or more methods (OP)............................................................	4.65	4.65	4.30	3.90	3.90	3.90
“ 2285 Chorionic gonadotrophin, quantitative estimation of by serial dilution for assessment of hormone—producing neoplasm by one or more methods (not associated with the service specified in item 2272) (SP) .................	18.80	18.80	17.20	15.80	15.80	15.80
“ 2286 Chorionic gonadotrophin, quantitative estimation of by serial dilution for assessment of hormone—producing neoplasm by one or more methods (not associated with the service specified in item 2273) (OP) ................	14.10	14.10	12.90	11.85	11.85	11.85
“ Division 9—Simple Basic Pathology Tests
“ 2334 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count—one procedure ...........................	1.90	1.90	1.75	1.60	1.60	1.60
“ 2335 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count—two procedures .........................	2.80	2.80	2.55	2.35	2.35	2.35
“ 2336 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count—three or more procedures ........	3.75	3.75	3.45	3.15	3.15	3.15
“ 2342 Microscopical examination of urine.........	1.90	1.90	1.75	1.60	1.60	1.60
“ 2346 Pregnancy test by one or more immunochemical methods ...................	4.65	4.65	4.30	3.90	3.90	3.90
“ 2352 Microscopical examination of wet film other than urine .......................................	2.80	2.80	2.55	2.35	2.35	2.35
“ 2357 Microscopical examination of gram stained film...............................................	3.75	3.75	3.45	3.15	3.15	3.15
“ 2362 Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method......................................................	0.90	0.90	0.85	0.75	0.75	0.75
“ 2369 Microscopical examination screening for fungi in skin, hair or nails—one or more sites..................................................	2.80	2.80	2.55	2.35	2.35	2.35

Schedule—continued

“ 2374 Mantoux test ................................................	4.65		4.65	4.30	3.90	3.90	3.90
“ 2382 Casoni test for hydatid disease .................	4.65		4.65	4.30	3.90	3.90	3.90
“ 2388 Schick test ....................................................	4.65		4.65	4.30	3.90	3.90	3.90
“ 2392 Seminal examination for presence of spermatozoa ............................................	2.80		2.80	2.55	2.35	2.35	2.35 ”.
8. Before item 2451, insert (in Part 7a) the following items:—
“ 2430 Erythrocyte radioactive uptake survival time ...........................................................	40.00		40.00	40.00	40.00	40.00	40.00
“ 2432 Blood volume Cr51  ...................................	16.00		16.00	16.00	16.00	14.20	16.00
“ 2434 Radioiodine thyroid uptake ......................	16.00		16.00	16.00	16.00	14.20	14.20
“ 2438 Gastrointestinal blood loss estimation with radioactive chromium involving serial examinations of stool specimens	32.00		32.00	32.00	32.00	32.00	32.00
“ 2441 Radioiodine, urinary estimation ...............	11.00		11.00	11.00	11.00	11.00	11.00
“ 2443 Protein bound radioactive iodine test ......	16.00		16.00	16.00	36.00	16.00	16.00
“ 2448 Radioactive B12 absorption test (Schilling test)..........................................	17.60		17.60	17.60	17.60	17.60	17.60”.
9. After item 3103, insert the following item:—
“ 3104 Repair of full thickness laceration of ear, eyelid or nose with accurate apposition of each layer of tissue (AU 10) ............	79.00	79.00		79.00	79.00	79.00	79.00”.
10. Omit item 3157, substitute the following items:—
“ 3157 Biopsy of bone marrow by trephine using an open approach (AU 5).......................	34.00	34.00		34.00	34.00	34.00	34.00
“ 3158 Biopsy of bone marrow by trephine using a percutaneous approach with a Jamshidi needle or similar device (AU 5)................................................................	38.60	38.60		18.60	18.60	18.60	18.60”.
11. Omit items 3219, 3228 and 3229, substitute the following items:—
“ 3219 Tumour, cyst, ulcer or scar, removal of cutaneous, subcutaneous or in mucous membrane, up to 3 centimetres in diameter, not covered by item 3221, 3223, 3225 or 3226 (G) (AU 6) ...........	30.00	30.00		30.00	30.00	30.00	30.00
“ 3220 Tumour, cyst, ulcer or scar, removal of cutaneous, subcutaneous or in mucous membrane, up to 3 centimetres in diameter, not covered by item 3222. 3224, 3225 or 3226 (S) (AU 6).............	39.50	39.50		39.50	39.50	39.50	39.50
“ 3221 Tumours, cysts, ulcers, or scars, removal of cutaneous, subcutaneous or in mucous membrane, up to 3 centimetres in diameter—where the procedure is performed on more than 3 but not more than 10 lesions (G) (AU 9)................................................................	79.00	79.00		79.00	79.00	79.00	79.00
“ 3222 Tumours, cysts, ulcers or scars, removal of cutaneous, subcutaneous or in mucous membrane, up to 3 centimetres in diameter—where the procedure is performed on more than 3 but not more than 10 lesions (S) (AU 9)................................................................	100.00	100.00		100.00	100.00	100.00	100.00

Schedule—continued

“ 3223 Tumours, cysts, ulcers or scars, removal of cutaneous, subcutaneous or in mucous membrane, up to 3 centimetres in diameter—where the procedure is performed on snore than 10 but not more than 20 lesions (G) (AU 13).................................................	106.00	106.00	106.00	106.00	106.00		106.00
“ 3224 Tumours, cysts, ulcers or scars, removal of cutaneous, subcutaneous or in mucous membrane, op to 3 centimetres in diameter—where the procedure is performed on more than 10 but not more than 20 lesions (S) (AU 13) ................................................	126.00	126.00	126.00	126.00	126.00		126.00
“ 3225 Tumours, cysts, ulcers or scars, removal of cutaneous, subcutaneous or in mucous membrane, up to 3 centimetres in diameter—where the procedure is performed on more than 20 but not more than 50 lesions (AU 15)..........................................................	158.00	158.00	158.00	158.00	158.00		158.00
“ 3226 Tumours, cysts, ulcers or scars, removal of cutaneous, subcutaneous or in mucous membrane, up to 3 centimetres in diameter—where the procedure is performed on more than 50 lesions (AU 17)..............................	210.00	210.00	210.00	210.00	210.00		210.00
“ 3229 Tumour, cyst, ulcer or scar, removal of cutaneous, subcutaneous or in mucous membrane, up to 3 centimetres in diameter, not covered by item 3230 (D) (AU 6) ....................	39.50	39.50	39.50	39.50	39.50		39.50
“ 3230 Tumours, cysts, ulcers or scars, removal of cutaneous, subcutaneous or in mucous membrane, up to 3 centimetres in diameter—where the procedure is performed on more than 3 but no more than 10 lesions (D) (AU 9) ....................................................	100.00	100.00	100.00	100.00	100.00		100.00 ”.
12. Omit item 3308, substitute the following items:—
“ 3309 Lipectomy—tranverse wedge excision of abdominal apron; or lipectomy with wedge excision of skin elsewhere in body (AU 10)................	140.00	140.00	140.00	140.00	140.00	140.00
“ 3310 Lipectomy—subumbilical excision with undermining of skin edges and strengthening of musculoaponeurotic wall (AU 12) .........................................	210.00	210.00	210.00	210.00	210.00	210.00
“ 3311 Lipectomy—radical abdominoplasty (Pitanguy type or similar) with excision, of skin and subcutaneous tissue, repair of musculo-aponeurotic layer and transposition of umbilicus (AU 18) .................................................	310.00	310.00	310.00	310.00	310.00	310.00 ”
13, Omit items 3330, 3331, 3332, 3338, 3342and 3346, substitute the following items:—
“ 3330 Keratoses, warts or similar lesions —electrosurgical destruction, chemotherapy or surgical removal—each attendance at which the procedure is performed on not more than five lesions (AU 4)......................	16.80	20.00	15.00	15.00	15.00		15.00

Schedule—continued

“ 3331 Keratoses, warts or similar lesions—electrosurgical destruction, chemotherapy or surgical removal of—each attendance at which the procedure is performed on not more than five lesions (D) (AU 4) .............	16.80	20.00	15.00				15.00				15.00				15.00
“ 3332 Keratoses, warts or similar lesions—electrosurgical destruction, chemotherapy or surgical removal of—each attendance at which the procedure is performed on more than five but not more than ten lesions (AU 5) ....................................	21.50	21.50	16.80				16.80				16.80				16.80
“ 3338 Keratoses, warts or similar lesions—electrosurgical destruction, chemotherapy or surgical removal of—each attendance at which the procedure is performed on more than ten but not more than fifteen lesions (AU 6)......................................	27.00	25.50	25.50				25.50				25.50				25.50
“ 3342 Keratoses, warts or similar lesions—electrosurgical destruction, chemotherapy or surgical removal of—each attendance at which the procedure is performed on more than fifteen but not more than, twenty lesions (AU 7)........................	29.00	27.00	27.00				27.00				27.00				27.00
“ 3346 Keratoses, warts or similar lesions—electrosurgical destruction, chemotherapy or surgical removal of—each attendance at which the procedure is performed on more than 20 lesions (AU 8)........................	34.00	30.00	30.00				30.00				30.00				30.00 ”.
14. Omit item 3889, substitute the following items:—
“ 3889 Vagotomy, highly selective; or vagotomy, trunkal or selective, with pyloroplasty or gastroenterostomy (AU 13) ................................................	260.00	260.00	260.00	260.00				260.00				260.00
“ 3891 Vagotomy, highly selective with pyloroplasty or gastroenterostomy (AU 13).................................................................	310.00	310.00	310.00	310.00				310.00				310.00 ”.
15. Omit item 4693, substitute the following items:—
“ 4693 Major artery or vein of neck or extremity, repair of wound of, with restoration of continuity (AU 13) ...	225.00	225.00	225.00	225.00				225.00				225.00
“ 4695 Microvascular repair using operating microscope with restoration of continuity of artery or vein of distal extremity or digit (AU 14)	340.00	340.00	340.00	340.00				340.00				340.00 ”.
36. After item 4754, insert the following item:—
“ 4756 Micro-arterial or micro-venous graft using operating microscope (AU 22)	635.00	635.00	635.00		635.00				635.00				635.00 ”.
17. After item 4762, insert the following item:—
“ 4764 Microvascular anastomosis of artery or vein using operating microscope, for reimplantation of limb or digit or free transfer of tissue (AU 38) .................................................................	555.00	555.00	555.00			555.00				555.00				555.00 ”.

Schedule—continued

18. After item 4804, insert the following item:—
“ 4806 Intra-aortic balloon for counterpulsation, operation for insertion by arteriotomy, or removal of and arterioplasty (AU 14) ............	158.00	158.00	158.00	158.00	158.00	158.00 ”.
19. Omit item 5977, substitute the following item:—
“ 5977 Urethropexy (Marshall-Marchetti operation) (AU 9)................................	210.00	210.00	210.00	210.00	210.00	210.00 ”.
20. Omit item 6701, substitute the following item:—
“ 6701 Anophthalmic orbit, insertion of cartilage or artificial implant as a delayed procedure, or removal of implant from socket (AU 9) .............	110.00	110.00	110.00	110.00	110.00	110.00 ”.
21. Omit item 8113, substitute the following item:—
“ 8113 Joint, repair of capsule or ligament of, or internal fixation of to stabilize joint (AU 7)..........................................	128.00	128.00	128.00	128.00	128.00	128.00 ”.
22. Omit items 8486, 8488, 8490 and 8492, substitute the following items:—
“ 8485 Direct flap repair (cross arm, abdominal or similar), first stage (AU 11) ................................................	146.00	146.00	146.00	146.00	146.00	146.00
“ 8486 Direct flap repair (cross arm, abdominal or similar), second stage (AU 9) ..................................................	73.00	73.00	73.00	73.00	73.00	73.00
“ 8487 Direct flap repair, cross leg, first stage (AU 13) ................................................	315.00	315.00	315.00	315.00	315.00	315.00
“ 8488 Direct flap repair, cross leg, second stage (AU 10)......................................	140.00	140.00	140.00	140.00	140.00	140.00
“ 8490 Direct flap repair, small (cross finger or simitar), first stage (AU 7) ..........	80.00	80.00	80.00	80.00	80.00	80.00
“ 8492 Direct flap repair, small (cross finger or similar), second stage (AU 7)......	3.7.00	37.00	37.00	37.00	37.00	37.00 ”.
23. Omit item 8510, substitute the following items:—
“ 8509 Free grafts (split skin) to burns, including excision of burned tissue—involving not more than 2,5 per centum of total body surface (AU 8) ..................................................	95.00	95.00	95.00	95.00	95.00	95.00
“ 8510 Free grafts (split skin) to burns, including excision of burned tissue—involving more than 2,5 per centum of total body surface (AU 14)..........................................................	215.00	215.00	215.00	215.00	215.00	215.00
“ 8511 Free grafts (homograft split skin) to burns, including excision of burned tissue—involving more than 2,5 per centum of total body surface (AU 13)   ........................................................	200.00	200.00	200.00	200.00	200.00	200.00 ”.
24. Omit item 8516, substitute the following item:—
“ 8516 Free grafts (split skin) including elective dissection, extensive; or inlay graft using a mould, insertion of and removal of mould (AU. 11)..	186.00	186.00	186.00	186.00	186.00	186.00 ”.
25. Omit items 8578, 8580 and 8582, substitute the following items:—
“ 8578 Osteotomy or osteectomy of maxilla (other than alveolar margins) or zygoma or both for congenital or post-traumatic malformation, not covered by any other item in this Part (AU 11)........................................	186.00	1:86.00	186.00	186.00	186.00	186.00

Schedule—continued

“ 8580 Osteotomy or osteectomy of maxilla (other than alveolar margins) or zygoma or both for congenital or post-traumatic malformation, not covered by any other item in this Part (D) (AU 11) ..................................	186.00	186.00	186.00	186.00	186.00	186.00
“ 8582 Whole thickness reconstruction of eyelid other than by direct suture only (AU 10)  .......................................	186.00	186.00	186.00	186.00	186.00	186.00”.
26. Omit item 8590, substitute the following items:—
“ 8589 Reduction of lower eyelid of one eye (AU 8) ....................................................

100.00	100.00	100.00	100.00	100.00	100.00
“ 8591 Reduction of upper eyelid of one eye (AU 7) ..................................................	74.00	74.00	74.00	74.00	74.00	74.00 ”.
27. Omit item 8600, substitute the following item:—
“ 8600 Rhinoplasty or similar contour restoration of the face, involving autogenous bone or costal cartilage graft (AU 13) ......................................	395.00	395.00	395.00	395.00	395.00	395.00 ”.
28. Omit item 8606, substitute the following item:—
“ 8606 Composite graft to nose or ear (AU 11)	158.00	158.00	158.00	158.00	158.00	158.00 ”.
29. Omit item 8622, substitute the following item:—
“ 8622 Cleft lip, unilateral—primary repair (AU 12).................................................	200.00	200.00	200.00	200.00	200.00	200.00 ”
30. Omit item 8626.